Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

CTKB
Cytek Biosciences, Inc. Common Stock
stock NASDAQ

At Close
May 9, 2025 3:59:47 PM EDT
2.92USD-22.955%(-0.87)2,222,350
2.92Bid   2.93Ask   0.01Spread
Pre-market
May 9, 2025 9:28:30 AM EDT
3.13USD-17.414%(-0.66)99,876
After-hours
May 8, 2025 4:04:30 PM EDT
3.67USD-3.038%(-0.12)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 5, 2022
11:07AM EST  Stocks That Hit 52-Week Lows On Wednesday   Benzinga
10:10AM EST  Cytek Biosciences Expands Fremont Headquarters   Benzinga
Nov 17, 2021
10:03AM EST  Cytek Biosciences Reports Has Shipped 1K Of Its Cell Analysis Systems   Benzinga
10:00AM EST  Cytek Biosciences Marks Milestone Achievement with   GlobeNewswire Inc
Nov 9, 2021
11:13AM EST  Cytek Biosciences Q3 EPS $0.02, Inline, Sales $34.40M Beat $33.39M Estimate   Benzinga
Nov 8, 2021
04:05PM EST  Cytek Biosciences, Inc. (Cytek Biosciences or Cytek) (Nasdaq: CTKB) today reported financial results for the third quarter ended September30, 2021.   GlobeNewswire Inc
05:06AM EST  Earnings Scheduled For November 8, 2021   Benzinga
Nov 3, 2021
09:19AM EDT  Cytek Biosciences Acquires Tonbo Biosciences' Cell Analysis Business; No Financial Terms Disclosed   Benzinga
08:00AM EDT  Cytek Biosciences Acquires Tonbo Biosciences   GlobeNewswire Inc
Oct 26, 2021
04:05PM EDT  Cytek Biosciences, Inc. (Cytek Biosciences or Cytek) (Nasdaq: CTKB), today announced it will report financial results for the third quarter 2021 after market close on Monday, November 8th, 2021. The companys management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.   GlobeNewswire Inc
Oct 7, 2021
10:00AM EDT  Cytek Biosciences Highlights Introduction Of New 25-Color Immunoprofiling Assay   Benzinga
10:00AM EDT  Cytek Biosciences Introduces New 25-Color   GlobeNewswire Inc
Sep 16, 2021
07:48AM EDT  The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study   Benzinga
Sep 2, 2021
04:05PM EDT  Cytek Biosciences, Inc. (Cytek Biosciences or Cytek) (Nasdaq: CTKB) today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference.   GlobeNewswire Inc
04:03PM EDT  Cytek Biosciences, Inc. (Cytek Biosciences or Cytek) (Nasdaq: CTKB) today reported financial results for the second quarter ended June30, 2021.   GlobeNewswire Inc
Aug 30, 2021
04:15PM EDT  Cytek Biosciences Says On Aug. 25 Entered Into Supply Agreement With Coherent; Coherent To Sell, Supply To Co Laser Products   Benzinga
Aug 17, 2021
12:05PM EDT  Cowen & Co. Initiates Coverage On Cytek Biosciences with Outperform Rating   Benzinga
10:09AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2021   Benzinga
08:10AM EDT  Morgan Stanley Initiates Coverage On Cytek Biosciences with Equal-Weight Rating, Announces Price Target of $26   Benzinga
06:12AM EDT  Goldman Sachs Initiates Coverage On Cytek Biosciences with Buy Rating, Announces Price Target of $28   Benzinga
05:29AM EDT  Piper Sandler Initiates Coverage On Cytek Biosciences with Overweight Rating, Announces Price Target of $28   Benzinga
Aug 15, 2021
12:16PM EDT  The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow   Benzinga
11:06AM EDT  The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow   Benzinga
Aug 12, 2021
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
Aug 5, 2021
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
Aug 4, 2021
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
Aug 3, 2021
07:55AM EDT  The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business   Benzinga
Aug 2, 2021
04:01PM EDT  Cytek Biosciences Announces Full Exercise of   GlobeNewswire Inc
Jul 28, 2021
10:21AM EDT  3 Stocks Insiders Are Buying   Benzinga
10:14AM EDT  The IPO Recap Party Is Everything But Over   Benzinga
Jul 27, 2021
06:00PM EDT  Cytek Biosciences Announces Closing of Its Initial Public Offering   GlobeNewswire Inc
Jul 23, 2021
03:00PM EDT  Cell Analysis Instruments Provider Cytek Biosciences Kick Starts Trading After Pricing IPO At $17   Benzinga
12:03PM EDT  Cytek Biosciences Shares Open For Trade At $20.10; IPO Priced At $17/Share   Benzinga
09:10AM EDT  Cytek Biosciences Shares Will Open For Quote At 9:50 a.m. EDT, Expected To Open For Trade After 10 a.m. EDT; IPO Priced At $17/Share   Benzinga
07:45AM EDT  The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC